Standard BioTools
LAB
LAB
86 hedge funds and large institutions have $70.2M invested in Standard BioTools in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 40 closing their positions.
Holders
86
Holders Change
-23
Holders Change %
-21.1%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
28
Closed
40
Calls
$109K
Puts
$352K
Net Calls
-$243K
Net Calls Change
+$420K
Top Buyers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$3.18M |
| 2 |
2
Balyasny Asset Management
Chicago,
Illinois
|
$1.82M |
| 3 |
3
Millennium Management
New York
|
$2.17M |
| 4 |
E
4
Ergoteles
New York
|
$557K |
| 5 |
JCP
5
Jennifer C. Price
|
$392K |
